 Andrew Li-Jen Kung, MD, PhD
Previous |
Next
|
Return to Search Results
Departments/Divisions
Hematology/Oncology Medicine Transplantation
Specialties
bone marrow and stem cell transplantation hematology/oncology oncology
Services/Programs
Bone Marrow and Stem Cell Transplantation Oncology
Clinical Title
Assistant in Medicine
Academic Appointment
Assistant Professor in Pediatrics, Harvard Medical School
Board Certification(s)
Pediatric Hematology/Oncology
|
| |
Medical/Dental School
Stanford University School of Medicine, Stanford, CA (1994)
Internship
Children's Hospital Boston, Boston, MA (07/94 to 06/95)
Residency
Pediatrics, Children's Hospital Boston, Boston, MA (07/95 to 06/96)
Fellowship
Children's Hospital Boston/Dana Farber Cancer Institute, Boston, MA (07/96 to 06/99)
Development of targeted therapies
Cancer Cell 2005, 7: 129
Clin Cancer Res 2006, 12: 6765
PLOS Med 2007, 4: e122
J Clin Invest 2008, 188: 3109
Role of hypoxia in tumor growth
Cancer Cell 2004, 5: 221
Proc Natl Acad Sci USA 2009, 106: 4260
In vivo imaging of tumor growth, metastasis and molecular pathways
Am J Pathol 2006, 168: 2074
Mol Cancer Therap 2007, 6: 1951
Leukemia 2008, 22: 66
Mol Imaging 2009, 8: 140
Development of targeted cancer therapies; Tumor hypoxia; In vivo imaging
Role of p300 and CBP transcriptional co-activators in hematopoiesis, stem cell renewal, cell adhesion and tumor suppression (Genes Dev 14:272, 2000; Cell 102:839, 2000; Proc Natl Acad Sci USA 12;99:14789, 2002; Science 300: 342, 2003; Nat Struct Biol 10: 504, 2003)
Role of hypoxia-inducible transcription in tumor growth (Nat Med 6:1335, 2000; Proc Natl Acad Sci USA 99:5367, 2002; Cancer Cell 6:33, 2004)
In vivo imaging of tumor growth, metastasis and molecular pathways (Cancer Cell 3:173, 2003; Proc Natl Acad Sci USA 100:13513, 2003; Science 305:1466, 2004; Cancer Cell 9:473, 2006)
Inhibition of insulin-like growth factor receptor-1 as a therapeutic strategy for cancer (Cancer Cell 5:221, 2004)
Development of targeted cancer therapies (Cancer Cell 6:33, 2004)( Cancer Cell 5:221, 2004; Cancer Cell 7:129, 2005; Blood 107:1092, 2006)
Research site for Andrew Kung, MD, PhD
|
Previous |
Next
|
Return to Search Results
|
|
|